These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 11650028)
21. Protecting human research subjects and the public: the role of FDA disqualification of clinical investigators. Nightingale SL Food Drug Cosmet Law J; 1980 Sep; 35(9):484-92. PubMed ID: 11661914 [No Abstract] [Full Text] [Related]
22. Regulation of drug treatments for HIV and AIDS: a contractarian model of access. Salbu SR Yale J Regul; 1994; 11(2):401-53. PubMed ID: 11660141 [No Abstract] [Full Text] [Related]
23. Perspectives on the FDA status of drug products manufactured by the recombinant DNA technique. Korwek EL; Trinker DS Food Drug Cosmet Law J; 1981 Oct; 36(10):517-35. PubMed ID: 11650658 [No Abstract] [Full Text] [Related]
24. AIDS and the FDA: an ethical case for limiting patient access to new medical therapies. Shorr AF IRB; 1992; 14(4):1-5. PubMed ID: 11651391 [No Abstract] [Full Text] [Related]
25. Rules to protect drug-test participants via follow-up exams are slated by FDA. Spivak J Wall St J (East Ed); 1976 Mar; ():5. PubMed ID: 11649042 [No Abstract] [Full Text] [Related]
26. Vaccination for AIDS: legal and ethical challenges from the test tube, to the human subject, through to the marketplace. Gostin L AIDS Public Policy J; 1987; 2(2):9-16. PubMed ID: 11650032 [No Abstract] [Full Text] [Related]
27. U.S. permits AIDS patients to use unproved drug. Kolata G N Y Times Web; 1989 Jan; ():A1, B6. PubMed ID: 11646713 [No Abstract] [Full Text] [Related]
28. AIDS and drug pricing: in search of a policy. Salbu SR Wash Univ Law Q; 1993; 71(3):691-734. PubMed ID: 11652750 [No Abstract] [Full Text] [Related]
29. AIDS: at the limits of the law. Wertheimer E Villanova Law Rev; 1989 Sep; 34(5):755-69. PubMed ID: 11651161 [No Abstract] [Full Text] [Related]
30. Considering experimentation and elusive truth: informed consent made difficult. Brodeur D Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444 [No Abstract] [Full Text] [Related]
31. Shaking up the status quo: how AIDS activists have challenged drug development and approval procedures. Dunbar MM Food Drug Cosmet Law J; 1991 Sep; 46(5):673-706. PubMed ID: 11651380 [No Abstract] [Full Text] [Related]
32. Drugs--Federal Drug Administration ban on Laetrile treatments for terminally ill cancer patients is arbitrary and capricious. Bitting TH Tulsa Law J; 1978; 14():222-5. PubMed ID: 11662799 [No Abstract] [Full Text] [Related]
33. Freedom of choice in medical treatment: reconsidering the efficacy requirement of the FDCA. Clinite BJ Loyola Univ Chic Law J; 1977; 9(1):205-26. PubMed ID: 11661566 [No Abstract] [Full Text] [Related]
34. Trial of experimental AIDS drug to be continued, with revisions. Kolata G N Y Times Web; 1990 Mar; ():A1, A15. PubMed ID: 11646750 [No Abstract] [Full Text] [Related]
35. Mandating research with children. Baylis F IRB; 1999; 21(1):10-1. PubMed ID: 11657966 [No Abstract] [Full Text] [Related]
36. F.D.A. gives quick approval to two drugs to treat AIDS. Kolata G N Y Times Web; 1989 Jun; ():A1, B4. PubMed ID: 11646728 [No Abstract] [Full Text] [Related]
37. In business to treat cancer. Henig RM N Y Times Mag; 1986 Nov; ():68, 70, 78, 80+. PubMed ID: 11647805 [No Abstract] [Full Text] [Related]
38. Informed consent: the FDA's perspective. Bagley G Food Drug Law J; 1993; 48(2):181-6. PubMed ID: 11653141 [No Abstract] [Full Text] [Related]
39. Cost of HIV drugs. American Public Health Association Am J Public Health; 1991 Feb; 81(2):250. PubMed ID: 11642863 [No Abstract] [Full Text] [Related]
40. The regulation of clinical investigators. Endries RN Food Drug Cosmet Law J; 1980 Jul; 35(7):415-23. PubMed ID: 11661860 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]